ZA9710579B - 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists. - Google Patents

2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists.

Info

Publication number
ZA9710579B
ZA9710579B ZA9710579A ZA9710579A ZA9710579B ZA 9710579 B ZA9710579 B ZA 9710579B ZA 9710579 A ZA9710579 A ZA 9710579A ZA 9710579 A ZA9710579 A ZA 9710579A ZA 9710579 B ZA9710579 B ZA 9710579B
Authority
ZA
South Africa
Prior art keywords
imidazolinylaminobenzoxazole
alpha
compounds useful
adrenoceptor agonists
adrenoceptor
Prior art date
Application number
ZA9710579A
Other languages
English (en)
Inventor
Raymond Todd Henry
Russell James Sheldon
William Lee Seibel
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of ZA9710579B publication Critical patent/ZA9710579B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA9710579A 1996-11-25 1997-11-25 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists. ZA9710579B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3178796P 1996-11-25 1996-11-25

Publications (1)

Publication Number Publication Date
ZA9710579B true ZA9710579B (en) 1998-06-25

Family

ID=21861392

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710579A ZA9710579B (en) 1996-11-25 1997-11-25 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists.

Country Status (18)

Country Link
US (1) US6110952A (es)
EP (1) EP0944622A1 (es)
JP (1) JP2001506601A (es)
KR (1) KR20000069128A (es)
AU (1) AU736992B2 (es)
BR (1) BR9713537A (es)
CA (1) CA2272683A1 (es)
CO (1) CO4910150A1 (es)
CZ (1) CZ183699A3 (es)
HU (1) HUP0002966A3 (es)
ID (1) ID22060A (es)
IL (1) IL130094A (es)
NO (1) NO313755B1 (es)
PE (1) PE16599A1 (es)
SK (1) SK74999A3 (es)
TR (1) TR199901486T2 (es)
WO (1) WO1998023611A1 (es)
ZA (1) ZA9710579B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0002966A3 (en) * 1996-11-25 2001-10-29 Procter & Gamble 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
WO2000051625A1 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
EP1815206B1 (en) * 2004-10-13 2016-04-06 PTC Therapeutics, Inc. Compounds for nonsense suppression, and methods for their use
EP2218442A1 (en) 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US20100202979A1 (en) * 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of pulmonary diseases and conditions
US20100028266A1 (en) * 2008-08-01 2010-02-04 Alpha Synergy Development. Inc. Composition and methods for treating allergic response
US8952011B2 (en) 2008-08-01 2015-02-10 Eye Therapies Llc Compositions and methods for the treatment of nasal conditions
US20100197694A1 (en) * 2008-08-01 2010-08-05 Gerald Horn Compositions and methods for treatment of diseases and conditions with increased vascular permeability
US20110003823A1 (en) * 2008-08-01 2011-01-06 Alpha Synergy Development, Inc. Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
US20100203165A1 (en) 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of disorders or conditions of the eye
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US8987270B2 (en) 2009-07-27 2015-03-24 Eye Therapies Llc Formulations of selective alpha-2 agonists and methods of use thereof
JP6052685B2 (ja) * 2011-07-25 2016-12-27 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ α２アドレナリン受容体の調節因子としてのＮ−（イミダゾリジン−２−イリデン）−ヘテロシクロペンタ［ｂ］ピリジン誘導体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US3830804A (en) * 1972-11-20 1974-08-20 Eastman Kodak Co Fluorescent(pyrimidinotriazolyl)-2-styrylbenzoxazoles
US4398028A (en) * 1977-01-14 1983-08-09 Sandoz Ltd. Bicyclic heterocyclic amino derivatives
FR2521140A1 (fr) * 1982-02-05 1983-08-12 Synthelabo Derives d'imidazolidine, leur preparation et leur application en therapeutique
US5091528A (en) * 1990-09-12 1992-02-25 Allergan, Inc. 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
GB9110017D0 (en) * 1991-05-09 1991-07-03 Nat Res Dev Spectroscopic investigation using organometallic compounds
EP0741709B1 (en) * 1994-01-24 2001-07-25 Allergan Sales, Inc. Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
WO1996004270A1 (en) * 1994-08-04 1996-02-15 Synaptic Pharmaceutical Corporation Novel benzimidazole derivatives
KR100215541B1 (ko) * 1996-04-19 1999-08-16 박원훈 벤족사졸계 비선형 광학 유도체 및 이들로부터 얻어진고분자
HUP0002966A3 (en) * 1996-11-25 2001-10-29 Procter & Gamble 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists

Also Published As

Publication number Publication date
SK74999A3 (en) 2000-02-14
PE16599A1 (es) 1999-03-12
AU736992B2 (en) 2001-08-09
IL130094A (en) 2001-09-13
HUP0002966A3 (en) 2001-10-29
NO992500L (no) 1999-07-26
CZ183699A3 (cs) 1999-09-15
HUP0002966A2 (hu) 2001-09-28
CA2272683A1 (en) 1998-06-04
AU5438298A (en) 1998-06-22
WO1998023611A1 (en) 1998-06-04
JP2001506601A (ja) 2001-05-22
TR199901486T2 (xx) 1999-10-21
CO4910150A1 (es) 2000-04-24
KR20000069128A (ko) 2000-11-25
EP0944622A1 (en) 1999-09-29
NO992500D0 (no) 1999-05-25
BR9713537A (pt) 2000-03-21
ID22060A (id) 1999-08-26
IL130094A0 (en) 2000-02-29
NO313755B1 (no) 2002-11-25
US6110952A (en) 2000-08-29

Similar Documents

Publication Publication Date Title
ZA9710577B (en) 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists.
ZA989230B (en) Prostaglandin agonists.
ZA200100900B (en) 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists.
ZA97175B (en) Novel substituted imidazole compounds.
ZA97222B (en) Lubricating compositions.
ZA97223B (en) Lubricating compositions.
ZA967134B (en) Coolant compositions.
ZA9711092B (en) Novel compounds.
EP0670647A3 (en) Facility for real-time translation of administrative data.
ZA9710578B (en) Guanidinyl heterocycle compounds useful as Alpha-2 adrenoceptor agonists.
ZA972514B (en) Pro-fragrance compound.
ZA9710579B (en) 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists.
ZA9711567B (en) Compounds.
ZA975861B (en) Bromotiacumicin compounds.
EP0668270A3 (fr) Dérivés de 2-imidazoline-5-ones fongicides.
ZA971638B (en) Microbicidal composition.
ZA9710574B (en) 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists.
ZA992899B (en) Novel compound.
ZA9710575B (en) Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists.
IL130067A0 (en) 2-Imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
IL132384A0 (en) 5-(2-Imidazolinylamino) benzimidazole compounds useful as alpha - 2 adrenoceptor agonists
ZA973485B (en) Antimycotic ectoparasiticidal product-external use.
ZA979404B (en) Aspirinate compounds.
AU1345900A (en) Oxazolidinones useful as alpha 1a adrenoceptor antagonists
ZA987970B (en) Compounds useful as antiatherosclerotic agents.